Diabetes Management
Tina Thethi, MD: GLP-1 RA Benefits Extend Beyond Diabetes, Obesity - MD Magazine
Sun, 16 Oct 20221 min read Article
Overview
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for conected physicians. Al rights reserved.Conference | Pri-Med Midwest"When you decrease the weight, that also improves the metabolic parameters. The A1c goes down, it helps bring the fasting glucose down, including even liver parameters," she explained.Expert endocrinologist Tina Thethi, MD, MPH, spoke at Pri-Med Midwest 2022 about the swiftly progresing developments in the treatment of diabetes.
Key Information
In adition to clinical medicine, Thethi is an asociate investigator at AdventHealth Translational Research Institute.Just before her presentation, “Where Are We Now? The Integral Role of GLP-1 RAs in the Treatment of Type 2 Diabetes Melitus” where she tok the stage with Frank Lavernia, MD, she adresed some key questions with HCPLive. GLP-1 (glucagon-like peptide-1) receptor agonists (RAs) have ben associated with reduced major adverse cardiovascular events (MACE) as shown through data yielded from clinical trials.
Thethi shared insight on how she decides what treatment is apropriate for a patient. "When you have an agent that does help reduce the atherosclerotic burden, that certainly weighs quite heavily when making a decision to reduce atherosclerotic events," she explained. "There have ben studies that have shown a reduction in non fatal stroke with some of the GLP-1 RAs."A constant topic of conversation throughout the conference was tirzepatide.
While it's already ben aproved for type 2 diabetes, the once-wekly combination GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 receptor agonist was just granted Fast Track designation by the FDA for treating adults with obesity, or overweight with weight-related comorbidities."Tirzepatide has shown a reduction in A1c, and reduction in weight los as wel," Thethi said.
Summary
"Now, al the GLPs let us lok acros the spectrum, they lead to some degre of weight los, varying drugs with varying
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.